Nurix Therapeutics, Inc.
NRIX
$9.63
$0.101.05%
NASDAQ
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 485.78M | 549.68M | 609.58M | 448.05M | 443.14M |
| Total Receivables | 20.70M | 2.10M | 1.50M | 800.00K | 600.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.85M | 11.92M | 8.30M | 7.19M | 6.48M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 515.33M | 563.70M | 619.39M | 456.04M | 450.22M |
|
|
|||||
| Total Current Assets | 515.33M | 563.70M | 619.39M | 456.04M | 450.22M |
| Net Property, Plant & Equipment | 68.99M | 44.81M | 45.90M | 44.15M | 47.39M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.24M | 6.53M | 4.06M | 3.93M | 4.04M |
| Total Assets | 591.56M | 615.04M | 669.34M | 513.60M | 511.03M |
|
|
|||||
| Total Accounts Payable | 5.95M | 8.40M | 11.48M | 3.92M | 2.81M |
| Total Accrued Expenses | 35.05M | 40.34M | 34.48M | 26.26M | 21.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.24M | 6.64M | 8.01M | 6.55M | 7.93M |
| Total Finance Division Other Current Liabilities | 29.37M | 34.61M | 41.88M | 49.57M | 48.48M |
| Total Other Current Liabilities | 29.37M | 34.61M | 41.88M | 49.57M | 48.48M |
| Total Current Liabilities | 75.61M | 89.99M | 95.85M | 86.30M | 80.78M |
|
|
|||||
| Total Current Liabilities | 75.61M | 89.99M | 95.85M | 86.30M | 80.78M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 46.70M | 19.98M | 20.29M | 20.59M | 20.89M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 21.64M | 24.15M | 26.21M | 29.86M | 38.67M |
| Total Liabilities | 143.95M | 134.13M | 142.35M | 136.74M | 140.34M |
|
|
|||||
| Common Stock & APIC | 1.29B | 1.28B | 1.27B | 1.06B | 1.00B |
| Retained Earnings | -838.58M | -795.12M | -738.77M | -680.22M | -631.26M |
| Treasury Stock & Other | -20.00K | 226.00K | 150.00K | 344.00K | -135.00K |
| Total Common Equity | 447.60M | 480.92M | 526.99M | 376.86M | 370.69M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 447.60M | 480.92M | 526.99M | 376.86M | 370.69M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 447.60M | 480.92M | 526.99M | 376.86M | 370.69M |
|
|
|||||